Cited by 173Neuroscience and Neuropharmacology ResearchSchizophrenia research and treatmentAmino Acid Enzymes and Metabolism

The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.

Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia

Steullet, P., Neijt, H.C., Cuénod, M., Do, K.Q.·2006·Neuroscience

DOI 10.1016/j.neuroscience.2005.10.014

Open this paper in CoChat — free account

Abstract

Increasing evidence suggests that the metabolism of glutathione, an endogenous redox regulator, is abnormal in schizophrenia. Patients show a deficit in glutathione levels in the cerebrospinal fluid and prefrontal cortex and a reduction in gene expression of the glutathione synthesizing enzymes. We investigated whether such glutathione deficit altered synaptic transmission and plasticity in slices of rat hippocampus, with particular emphasis on NMDA receptor function. An approximately 40% decrease in brain glutathione levels was induced by s.c. administration of L-buthionine-(S,R)-sulfoximine, an inhibitor of glutathione synthesis. Such glutathione deficit did not affect the basal synaptic transmission, but produced several NMDA receptor-dependent and -independent effects. Glutathione deficit caused an increase in excitability of CA1 pyramidal cells. The paired-pulse facilitation was diminished in glutathione-depleted slices, in a manner that was independent of NMDA receptor activity. This suggests that lowering glutathione levels altered presynaptic mechanisms involved in neurotransmitter release. NMDA receptor-dependent long-term potentiation induced by high-frequency stimulation was impaired in glutathione-depleted slices. Pharmacologically isolated NMDA receptor-mediated field excitatory postsynaptic potentials were significantly smaller in L-buthionine-(S,R)-sulfoximine-treated than in control slices. Hypofunction of NMDA receptors under glutathione deficit was explained at least in part by an excessive oxidation of the extracellular redox-sensitive sites of the NMDA receptors. These results indicate that a glutathione deficit, like that observed in schizophrenics, alters short- and long-term synaptic plasticity and affects NMDA receptor function. Thus, glutathione deficit could be one causal factor for the hypofunction of NMDA receptors in schizophrenia.

Integrity signals

Registry

Crossref · 10.1016/j.neuroscience.2005.10.014

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory.
Tsien, J. Z., Huerta, P. T., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81827-9 · Cited by 1,782
Neuregulin 1 and Susceptibility to Schizophrenia
Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Short-Term Synaptic Plasticity
Zucker, R. S. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.000305 · Cited by 1,450
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291

Show all 87 references

Research works printed but not linked: 1

Cabungcal, 2005, Glutathione deficit during development induces anomalies in anterior cingulate GABA interneurones, Schizophr Bull, 31, 258

Sorted by citations

Selective neuronal vulnerability to oxidative stress in the brain
Wang, X. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00012 · Cited by 1,043
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial
Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
Javitt, D. C. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78003-5 · Cited by 568
N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
Self-citation
N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial
Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia
Gonzalez-Burgos, G., & Lewis, D. A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs010 · Cited by 478
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 482
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434
N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 414
Redox dysregulation, neurodevelopment, and schizophrenia
Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384
Self-citation
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371
Self-citation
Neurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K., Thaker, G. K., Winterer, G., & Hajós, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 340
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309
Self-citation
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304
Self-citation
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 299
The origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 294
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?
Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262
Self-citation
Glutamatergic theories of schizophrenia.
Javitt, D. C. (2010) · PubMed · Cited by 248
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234
Self-citation
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Lieberman, J. A., Bymaster, F. P., Meltzer, H. Y., Deutch, A. Y., Duncan, G. E., Marx, C. E., Aprille, J. R., Dwyer, D. S., Li, X., Mahadik, S. P., et al. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00107 · Cited by 225
Oxidative Stress in Traumatic Brain Injury
Fesharaki‐Zadeh, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113000 · Cited by 241
Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological Glutamatergic Signaling
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia
Cabungcal, J.-H., Counotte, D. S., Lewis, E. M., Tejeda, H. A., Piantadosi, P., Pollock, C., Calhoon, G. G., Sullivan, E. M., Presgraves, E., Kil, J., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.028 · Cited by 204
Self-citation
Redox Dysregulation Affects the Ventral But Not Dorsal Hippocampus: Impairment of Parvalbumin Neurons, Gamma Oscillations, and Related Behaviors
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202
Self-citation
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 193
The Glutathione System: A New Drug Target in Neuroimmune Disorders
Morris, G., Anderson, G., Dean, O. M., Berk, M., Gałecki, P., Martín-Subero, M., & Maes, M. H. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8705-x · Cited by 194
The Glutathione System in Parkinson’s Disease and Its Progression
Bjørklund, G., Peana, M., Maes, M., Dadar, M., & Severin, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.004 · Cited by 186
Inflammation in schizophrenia: A question of balance
Leza, J. C., García‐Bueno, B., Bioque, M., Arango, C., Parellada, M., Kim, Q., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 188
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Barron, H., Hafizi, S., Andreazza, A. C., & Mizrahi, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030651 · Cited by 183
Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?
Behrens, M. M., & B, T. J. S. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.002 · Cited by 163
Implications for reactive oxygen species in schizophrenia pathogenesis
Koga, M., Serritella, A. V., Sawa, A., & Sedlak, T. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.022 · Cited by 164
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000001 · Cited by 155
Glutathione and glutamate in schizophrenia: a 7T MRS study
Kumar, J., Liddle, E. B., Fernandes, C. C., Palaniyappan, L. K., Hall, E. L., Robson, S. E., Simmonite, M., Jan, F., Katshu, M. Z. U. H., Qureshi, A., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0104-7 · Cited by 159
The role of glutathione redox imbalance in autism spectrum disorder: A review
Bjørklund, G., Tinkov, A. A., Hosnedlová, B., Kizek, R., Ajsuvakova, O. P., Chirumbolo, S., Геннадиевна, С. М., Peana, M., Dadar, M., El-Ansary, A. K., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.017 · Cited by 156
Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression
Anderson, G., & Maes, M. H. J. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.014 · Cited by 146
Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain
Lanté, F., Meunier, J., Guiramand, J., Maurice, T., Cavalier, M., de Jesus Ferreira, M.-C., Aimar, R., Cohen-Solal, C., Vignes, M., & Barbanel, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.01.027 · Cited by 140
Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Baxter, P. S., Bell, K. F. S., Hasel, P., Kaindl, A. M., Fricker, M., Thomson, D., Cregan, S. P., Gillingwater, T. H., & Hardingham, G. E. (2015) · Nature Communications · doi:10.1038/ncomms7761 · Cited by 139
Animal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
Cuénod, M., Steullet, P., Cabungcal, J.-H., Dwir, D., Khadimallah, I., Klauser, P., Conus, P., & Kim, Q. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01374-w · Cited by 134
Self-citation
Late N‐acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation
Lanté, F., Meunier, J., Guiramand, J., De Jesus Ferreira, M., Cambonie, G., Aimar, R., Cohen‐Solal, C., Maurice, T., Vignes, M., & Barbanel, G. (2008) · Hippocampus · doi:10.1002/hipo.20421 · Cited by 124
Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models
Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124
Self-citation
Thinking Glutamatergically: Changing Concepts of Schizophrenia Based Upon Changing Neurochemical Models
Kantrowitz, J. T., & Javitt, D. C. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.6 · Cited by 120
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Egerton, A., Grace, A. A., Stone, J. M., Bossong, M. G., Sand, M. S., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.013 · Cited by 118
Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine
Baker, D. L., Madayag, A., Kristiansen, L. V., Meador‐Woodruff, J. H., Haroutunian, V. H., & Raju, I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301532 · Cited by 113
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017) · npj Schizophrenia · doi:10.1038/s41537-016-0003-3 · Cited by 110
Theranostic Biomarkers for Schizophrenia
Perković, M. N., Erjavec, G. N., Štrac, D. Š., Uzun, S., Kozumplik, O., & Pivac, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040733 · Cited by 113
Potential Roles of Redox Dysregulation in the Development of Schizophrenia
Perkins, D. O., Jeffries, C. D., & Do, K. Q. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.016 · Cited by 103
Antioxidant Therapies in Traumatic Brain Injury
Pietro, V. D., Yakoub, K. M., Caruso, G., Lazzarino, G., Signoretti, S., Barbey, A. K., Tavazzi, B., Lazzarino, G., Belli, A., & Amorini, A. M. (2020) · Antioxidants · doi:10.3390/antiox9030260 · Cited by 102
Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia
Brown, J. S. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm147 · Cited by 102
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
Tsugawa, S., Noda, Y., Tarumi, R., Mimura, Y., Yoshida, K., Iwata, Y., ElSalhy, M., Kuromiya, M., Kurose, S., Masuda, F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845820 · Cited by 111
Insights into CNS ageing from animal models of senescence
Yeoman, M. S., Scutt, G., & Faragher, R. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3230 · Cited by 98
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
Bentsen, H., Osnes, K., Refsum, H., Solberg, D. K., & Bøhmer, T. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.110 · Cited by 97
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
Sepehrmanesh, Z., Heidary, M., Akasheh, N., Akbari, H., & Heidary, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.001 · Cited by 97
Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96
Self-citation
Glutathione Restores the Mechanism of Synaptic Plasticity in Aged Mice to That of the Adult
Robillard, J. M., Gordon, G. R., Choi, H. B., Christie, B. R., & MacVicar, B. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020676 · Cited by 89
One-carbon metabolism and schizophrenia: current challenges and future directions
Krebs, M., Bellon, A., Mainguy, G., Jay, T. M., & Frieling, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.001 · Cited by 89
Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways
Anderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 86
Could Alzheimer’s Disease Originate in the Periphery and If So How So?
Morris, G., Berk, M., Maes, M. H. J., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1092-y · Cited by 86
Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: Relevance to schizophrenia
Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 83
Self-citation
Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial
Carmeli, C., Knyazeva, M. G., Cuénod, M., & Do, K. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029341 · Cited by 81
Self-citation
Effects of pre-natal alcohol exposure on hippocampal synaptic plasticity: Sex, age and methodological considerations
Fontaine, C. J., Patten, A. R., Sickmann, H. M., Helfer, J. L., & Christie, B. R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.014 · Cited by 83
The impact of glutathione metabolism in autism spectrum disorder
Bjørklund, G., Doşa, M. D., Maes, M. H. J., Dadar, M., Frye, R. E., Peana, M., & Chirumbolo, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105437 · Cited by 81
Stimulated Efflux of Amino Acids and Glutathione from Cultured Hippocampal Slices by Omission of Extracellular Calcium
Stridh, M. H., Tranberg, M., Weber, S. G., Blomstrand, F., & Sandberg, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704153200 · Cited by 72
Molecular Profiles of Parvalbumin-Immunoreactive Neurons in the Superior Temporal Cortex in Schizophrenia
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Passeri, E., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., et al. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.878339 · Cited by 67
Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating
Pitts, M. W., Raman, A. V., Hashimoto, A. C., Todorovic, C., Nichols, R. A., & Berry, M. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.017 · Cited by 67
Impaired Attention and Synaptic Senescence of the Prefrontal Cortex Involves Redox Regulation of NMDA Receptors
Guidi, M., Kumar, A., & Foster, T. C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3523-14.2015 · Cited by 63
Glutathione Modulates Ca2+ Influx and Oxidative Toxicity Through TRPM2 Channel in Rat Dorsal Root Ganglion Neurons
Nazıroğlu, M., Özgül, C., Çiğ, B., Doğan, S., & Uğuz, A. C. (2011) · The Journal of Membrane Biology · doi:10.1007/s00232-011-9382-6 · Cited by 63
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G. E., Bishehsari, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160989 · Cited by 67
Genetic Dysregulation of Glutathione Synthesis Predicts Alteration of Plasma Thiol Redox Status in Schizophrenia
Gysin, R., Kraftsik, R., Boulat, O., Bovet, P., Conus, P., Comte-Krieger, E., Polari, A. R., Steullet, P., Preisig, M., Bellier-Teichmann, T., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3463 · Cited by 62
Self-citation
Cocaine-Induced Adaptations in Cellular Redox Balance Contributes to Enduring Behavioral Plasticity
Uys, J. D. K., Knackstedt, L. A., Hurt, P., Tew, K. D., Manevich, Y., Hutchens, S., Townsend, D. M., & Kalivas, P. W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.143 · Cited by 62
Chronic stress, hippocampus and parvalbumin-positive interneurons: what do we know so far?
Zaletel, I. V., Filipović, D., & Puškaš, N. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0042 · Cited by 57
Glutathione-coordinated metal complexes as substrates for cellular transporters
Pearson, S. A., & Cowan, J. A. (2021) · Metallomics · doi:10.1093/mtomcs/mfab015 · Cited by 57
Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain
Stojković, T., Radonjić, N. V., Velimirović, M., Jevtić, G., POPOVIC, V. M., Doknić, M., & Petronijević, N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.013 · Cited by 53
Accelerating neuronal aging in in vitro model brain disorders: a focus on reactive oxygen species
Campos, P. B., Paulsen, B. S., & Rehen, S. K. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00292 · Cited by 55
Role of GABAergic antagonism in the neuroprotective effects of bilobalide
Kiewert, C., Kumar, V., Hildmann, O., Rueda, M., Hartmann, J., Naik, R. S., & Klein, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.10.042 · Cited by 52
Melatonin reverts methamphetamine-induced learning and memory impairments and hippocampal alterations in mice
Veschsanit, N., Yang, J., Ngampramuan, S., Viwatpinyo, K., Pinyomahakul, J., Lwin, T., Chancharoen, P., Rungruang, S., Govitrapong, P., & Mukda, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118844 · Cited by 47
Impairments in hippocampal synaptic plasticity following prenatal ethanol exposure are dependent on glutathione levels
Patten, A. R., Brocardo, P. S., Sakiyama, C., Wortman, R. C., Noonan, A., Gil‐Mohapel, J., & Christie, B. R. (2013) · Hippocampus · doi:10.1002/hipo.22199 · Cited by 45
The ameliorative effect ofN‐acetylcysteine against penconazole induced neurodegenerative and neuroinflammatory disorders in rats
Morgan, A. M., Hassanen, E. I., Ogaly, H. A., Dulmani, S. A. A., Al‐Zahrani, F. A. M., Galal, M. K., Kamel, S., Rashad, M. M., Ibrahim, M. A., & Hussien, A. M. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22884 · Cited by 45
Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138
Millan, M. J., & Brocco, M. (2008) · Therapies · doi:10.2515/therapie:2008041 · Cited by 44
Fluorescence Probe for Imaging N-Methyl- d -aspartate Receptors and Monitoring GSH Selectively Using Two-Photon Microscopy
Kwon, N., Lim, C. S., Ko, G., Ha, J., Lee, D., Yin, J., Kim, H. M., & Yoon, J. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02350 · Cited by 43
The impact of alcohol and tobacco use on in vivo glutathione in youth with bipolar disorder: An exploratory study
Chitty, K. M., Lagopoulos, J., Hickie, I. B., & Hermens, D. F. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.03.024 · Cited by 41
Potentiation of acid-sensing ion channels by sulfhydryl compounds
Cho, J.-H., & Askwith, C. C. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00598.2006 · Cited by 42
Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice
Tran, T.-V., Shin, E., Jeong, J. H., Lee, J., Lee, Y., Jang, C., Nah, S.-Y., Lei, X. G., Toriumi, K., Yamada, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0239-y · Cited by 42
Treatment in early psychosis with N-acetyl-cysteine for 6 months improves low-level auditory processing: Pilot study
Retsa, C., Knebel, J., Geiser, E., Ferrari, C., Jenni, R., Fournier, M., Alameda, L., Baumann, P., Clarke, S., Conus, P., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.008 · Cited by 40
Neurobiology of Schizophrenia Onset
Woo, T.-U. W. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_243 · Cited by 46
Neuroprotective effects of the ethanol stem bark extracts ofTerminalia ivorensisin ketamine-induced schizophrenia-like behaviors and oxidative damage in mice
Ben‐Azu, B., Aderibigbe, A. O., Ajayi, A. M., & Iwalewa, E. O. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1190382 · Cited by 38
A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia
Akter, K. A., Gallo, D., Martin, S. A., Myronyuk, N., Roberts, R. T., Stercula, K., & Raffa, R. B. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01265.x · Cited by 38
GLT‐1 upregulation impairs prepulse inhibition of the startle reflex in adult rats
Bellesi, M., Melone, M., Gubbini, A., Battistacci, S., & Conti, F. (2008) · Glia · doi:10.1002/glia.20798 · Cited by 36
Maternal high-fat diet-induced microbiota changes are associated with alterations in embryonic brain metabolites and adolescent behaviour
Ratsika, A., Codagnone, M. G., Bastiaanssen, T. F. S., Sardá, F. A. H., Lynch, C. M. K., Ventura‐Silva, A. P., Rosell‐Cardona, C., Caputi, V., Stanton, C., Fülling, C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.020 · Cited by 36
NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity
Hasam‐Henderson, L. A., Gotti, G. C., Mishto, M., Klisch, C., Gerevich, Z., Geiger, J. R. P., & Kovács, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-27830-2 · Cited by 34
Glutamatergic Neuroplasticity in Cocaine Addiction
Uys, J. D. K., & Reissner, K. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00009-0 · Cited by 31
NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans
de la Salle, S., Shah, D. K., Choueiry, J., Bowers, H., McIntosh, J. F., Ilivitsky, V., & Knott, V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00455 · Cited by 29
Schizophrenia: Redox Regulation and Volume Neurotransmission
Bókkon, I., & Antal, I. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596504 · Cited by 29
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
Veselinović, T., & Neuner, I. (2022) · CNS Drugs · doi:10.1007/s40263-022-00935-z · Cited by 31
N -acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
Benvenutti, R., Marcon, M., Reis, C. G., Nery, L. R., Miguel, C., Herrmann, A. P., Vianna, M. R. M. R., & Piato, Â. (2018) · PeerJ · doi:10.7717/peerj.4957 · Cited by 28
Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism
Genius, J., Geiger, J., Dölzer, A.-L., Benninghoff, J., Giegling, I., Hartmann, A. M., Möller, H., & Rujescu, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059395 · Cited by 29
Ginsenoside Re protects against phencyclidine-induced behavioral changes and mitochondrial dysfunction via interactive modulation of glutathione peroxidase-1 and NADPH oxidase in the dorsolateral cortex of mice
Tran, T.-V., Shin, E., Dang, D., Ko, S. K., Jeong, J. H., Nah, S.-Y., Jang, C., Lee, Y. J., Toriumi, K., Nabeshima, T., et al. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.019 · Cited by 26
Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study
Girgis, R. R., Baker, S. C., Mao, X., Gil, R. B., Javitt, D. C., Kantrowitz, J. T., Gu, M., Spielman, D. M., Ojeil, N., Xu, X., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.018 · Cited by 26
Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress
Chiang, T.-I., Yu, Y., Lin, C., & Lane, H. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.3.423 · Cited by 26

Authors: Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q.
Affiliations: Centre Hospitalier Universitaire Vaudois (CH)
Novartis (Switzerland) (CH)
University of Lausanne (CH)
ORCID: Steullet, P.
Cuénod, M.
Venue: Neuroscience
Publisher: Elsevier BV
Published: 2006-01
Volume: 137
Issue: 3
Pages: 807-819
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/j.neuroscience.2005.10.014
OpenAlex: W2004830149
Cited by: 173
References: 87
Citations by year: 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 13 · 2020: 6 · 2019: 6 · 2018: 10 · 2017: 12 · 2016: 11 · 2015: 12 · 2014: 11 · 2013: 9 · 2012: 16
FWCI: 2.65
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords: NMDA receptor hypofunction, synaptic plasticity, schizophrenia, L-buthionine sulfoximine, glutathione synthesis inhibition, paired-pulse facilitation, long-term potentiation, presynaptic neurotransmitter release, hippocampus, glutathione metabolism
MeSH terms: Animals, Antimetabolites, Electric Stimulation, Electrophysiology, Glutamate-Cysteine Ligase, Glutathione, Membrane Potentials, Synaptic Transmission, Neuronal Plasticity, Schizophrenia, Synapses, Receptors, N-Methyl-D-Aspartate, Rats, Wistar, Long-Term Potentiation, Buthionine Sulfoximine, Excitatory Postsynaptic Potentials, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks